Edward Nirenberg on Nostr: Long is also concerned that there is a lack of clinical effectiveness data with the ...
Long is also concerned that there is a lack of clinical effectiveness data with the updated pneumococcal vaccines. There is also significant uncertainty about the behavior of serotype 4 in the coming months, which will affect what needs to be done with PCV20 vs 21.
Published at
2024-06-27 19:47:59Event JSON
{
"id": "8173644415745eaaac4f53784a239905a24ebc16c364d52b71401bc3c1483961",
"pubkey": "c67b38e4c5023e985f04ae7ab6a6669cf463220e1b9ed54b897d1957004603a4",
"created_at": 1719517679,
"kind": 1,
"tags": [
[
"e",
"6eafb183a537b65238af1b5ef0d8c59e539c1d9742b1427a44dba4e1a99bf9a0",
"wss://relay.mostr.pub",
"reply"
],
[
"proxy",
"https://med-mastodon.com/users/enirenberg/statuses/112690310671453911",
"activitypub"
]
],
"content": "Long is also concerned that there is a lack of clinical effectiveness data with the updated pneumococcal vaccines. There is also significant uncertainty about the behavior of serotype 4 in the coming months, which will affect what needs to be done with PCV20 vs 21.",
"sig": "f723b576abcbee7a61daae4a5249509decd3fa805d0e170a6f51e8c7c647efdac2456a0807ae4d9ca52454f46e8dfe9ca8b3363120c6dd2980548c21b098745e"
}
